NCT00780780View on ClinicalTrials.gov

Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

October 31, 2012

Conditions
Diabetic Macular Edema
Interventions
DRUG

Triamcinolone + Nepafenac

Triamcinolone intravitreal injection 0,1 ml (4mg) Nepafenac 1 drop, tid, during 6 months

DRUG

triamcinolone intravitreal injection

triamcinolone intravitreal injection

Trial Locations (1)

04023062

Federal University of Sao Paulo - Dept. of Ophthalmology / Vision Institute, São Paulo

All Listed Sponsors
lead

Federal University of São Paulo

OTHER

NCT00780780 - Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema | Biotech Hunter | Biotech Hunter